Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

Abstract 3196: Analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRLX301, a nanoparticle of docetaxel

10.1158/1538-7445.am2020-3196 ◽

2020 ◽

Author(s):

Eiman Mukhtar ◽

Daniel Worroll ◽

Giuseppe Galletti ◽

Shelly Schuster ◽

Sarina A. Piha-Paul ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Drug Target ◽

Target Engagement ◽

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy

Theranostics ◽

10.7150/thno.44556 ◽

2020 ◽

Vol 10 (17) ◽

pp. 7645-7655

Author(s):

Katharina Kessel ◽

Robert Seifert ◽

Matthias Weckesser ◽

Wolfgang Roll ◽

Verena Humberg ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular Analysis ◽

Radioligand Therapy ◽

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e23025 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e23025-e23025

Author(s):

Darren W. Davis ◽

Asifa Haider ◽

Valerie Pierron ◽

Fabien Schmidlin

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Improved Enumeration of Circulating Tumor Cells and Correlation with Clinical Endpoints in Castration-Resistant Prostate Cancer Patients

Annals of Oncology ◽

10.1016/s0923-7534(20)33468-2 ◽

2012 ◽

Vol 23 ◽

pp. ix300-ix301

Author(s):

R.J. Amato ◽

V. Melnikova ◽

Y. Zhang ◽

W. Liu ◽

K. Anderes ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Clinical Endpoints ◽

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-015-1936-z ◽

2015 ◽

Vol 141 (8) ◽

pp. 1457-1464 ◽

Cited By ~ 16

Author(s):

M. Thalgott ◽

M. M. Heck ◽

M. Eiber ◽

M. Souvatzoglou ◽

G. Hatzichristodoulou ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Objective Response ◽

Response Assessment ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration–Resistant Prostate Cancer: Missing Parts in a Superb Study: Table 1.

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-0006 ◽

2009 ◽

Vol 15 (4) ◽

pp. 1504.2-1505 ◽

Cited By ~ 3

Author(s):

Johann S. de Bono ◽

Christopher Parker ◽

Howard I. Scher ◽

R. Bruce Montgomery ◽

M. Craig Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Quantitative Analysis ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Castration Resistant ◽

Survival Predictor

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients

Oncotarget ◽

10.18632/oncotarget.25019 ◽

2018 ◽

Vol 9 (27) ◽

pp. 19283-19293 ◽

Cited By ~ 31

Author(s):

Afroditi Nanou ◽

Frank A.W. Coumans ◽

Guus van Dalum ◽

Leonie L. Zeune ◽

David Dolling ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Extracellular Vesicles ◽

Circulating tumor cells as liquid biopsy for castration resistant prostate cancer patients treated with cabazitaxel

Annals of Oncology ◽

10.1093/annonc/mdx363.047 ◽

2017 ◽

Vol 28 ◽

pp. v36-v37

Author(s):

S. Salvi ◽

V. Conteduca ◽

V. Casadio ◽

P. Fici ◽

G. Gurioli ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Liquid Biopsy ◽